Cytosorbents Corporation (CTSO)

NCM – Цена в реальном времени. Валюта: USD

0.36

-0.10 (-21.30%)

При закрытии: Jun 26, 2026, 4:00 PM EDT

0.38

+0.02 (5.28%)

После закрытия: Jun 26, 2026, 5:29 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

Cytosorbents Corporation (CTSO)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Cytosorbents Corporation (CTSO)

Cytosorbents Corporation (CTSO) Q1 2026 Earnings Call Transcript

CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update

CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights

Cytosorbents Corporation (CTSO) Q4 2025 Earnings Call Transcript

CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026

CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Видео

No Data

Пресс-релизы

CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update

CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026

CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update

Search stocks

Cytosorbents Corporation (CTSO)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Cytosorbents Corporation (CTSO)

Cytosorbents Corporation (CTSO) Q1 2026 Earnings Call Transcript

CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update

CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights

Cytosorbents Corporation (CTSO) Q4 2025 Earnings Call Transcript

CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026

CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Видео

No Data

Пресс-релизы

CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update

CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026

CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update